ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“Abstract submission for the brand new ESMOTATAsia25 Congress is now open!
This first edition promises to bring the innovative and collaborative spirit of ESMO TAT to one of the most dynamic hubs in Asia, making the latest advances in early clinical trials accessible to everyone in the region.
Submission deadline: 29 April 2025.
Submit now!”